Related Experiment Video
Updated: Jan 1, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The role of statins in cardioembolic stroke
Bruno Kusznir Vitturi1, Rubens José Gagliardi1
1Department of Neurology, Santa Casa de São Paulo School of Medical Sciences, Dr. Cesário Motta Júnior Street 112 01221-020, São Paulo, Brazil.
Insights
Statin therapy, particularly simvastatin 40 mg and high-potency statins, may improve functional recovery and reduce stroke recurrence in patients with cardioembolic stroke.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Statin therapy is crucial for secondary stroke prevention.
- Evidence for statin use in cardioembolic stroke is limited.
- This study investigates statin effects on cardioembolic stroke outcomes.
Purpose of the Study:
- To evaluate the impact of statin therapy on neurological outcomes in cardioembolic stroke patients.
- To compare different statin dosages and potencies.
Main Methods:
- Prospective cohort study of 91 cardioembolic stroke patients.
- Classification into non-statin, simvastatin 20 mg, simvastatin 40 mg, and high-potency statin groups.
- Assessment of functional outcomes, stroke recurrence, cardiovascular events, and mortality over 2 years.
Main Results:
- Simvastatin 40 mg use was linked to significantly lower stroke recurrence.
- Patients on simvastatin 40 mg and high-potency statins showed superior functional recovery.
- No significant difference in major cardiovascular events or mortality was reported.
Conclusions:
- Statin therapy, especially simvastatin 40 mg and high-potency statins, shows promise for cardioembolic stroke patients.
- Benefits include reduced stroke recurrence and improved functional outcomes.
- Further research is warranted to confirm these findings.
Background:
Statin therapy has become one of the most important advances in stroke secondary prevention. Nevertheless, statin therapy in patients with cardioembolic stroke has not been supported by clinical evidence yet. This study aimed to investigate the effect of statins on the neurological outcomes after a cardioembolic stroke.
Methods:
We conducted a prospective cohort study including consecutive patients with cardioembolic stroke. Subjects were classified into non-statin, simvastatin 20 mg, simvastatin 40 mg, and high-potency statin groups. After 2 years, the functional outcome, stroke recurrence, major cardiovascular events, and mortality were assessed.
Results:
Among the 91 patients included in our cohort, there were 18 (19.8%) patients without statins, 30 (33.0%) with simvastatin 20 mg, 38 (41.7%) with simvastatin 40 mg and 5 (5.5%) with high-potency statins. Using simvastatin 40 mg was associated with a significantly lower incidence of stroke recurrence lower. Patients with simvastatin 40 mg and high-potency statins presented the best functional recovery throughout the follow-up (p < 0.01).
Conclusions:
The use of statins in patients with cardioembolic stroke may be beneficial in some cases, preventing stroke recurrence and improving functional outcomes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Atherosclerosis III: Management
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:27Coronary Artery Disease V: Interprofessional Care
01:23Atherosclerosis IV: Nursing Management
01:26Coronary Artery Disease IV: Preventive Measures